![](/img/cover-not-exists.png)
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
Guoqing Wei, Shamudheen Rafiyath, Delong LiuVolume:
3
Language:
english
DOI:
10.1186/1756-8722-3-47
Date:
December, 2010
File:
PDF, 298 KB
english, 2010